You forget that it is also moving into an untapped market, in which adheres to bp's needs and will enhance bp operations (also it will take liability and chance of failure off of bps shoulders)-- but also makes it easier on the fda by dealing with 1 entity.
Nothing gets in without bps approval--- this company is designed to suck the teat of bp and flourish from its hairy nipples.
Bmsn is a new and unique concept which is utter brilliance.
News 
Market Data 
Discover 
AI
